Category: Antisense & RNAi Technology
Global Antisense & RNAi Technology
-
Global RNA Interference (RNAi) Drug Delivery Market Growth 2024-2030
... demand in downstream market, the RNA Interference (RNAi) Drug Delivery is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth ... Read More
-
Global Antisense & RNAi Therapeutics Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Antisense & RNAi Therapeutics is forecast to a readjusted size of US$ 1268.5 million by 2030 with a CAGR of 4.4% during review period. The research report highlights ... Read More
-
RNA Interference (RNAi) Pesticides Market Forecasts to 2030 – Global Analysis By Type (Synthetic RNAi Pesticides and Natural RNAi Pesticides), Mode of Action (Gene Silencing and RNA Interference), Crop Type, Application, End User and By Geography
... Geography According to Stratistics MRC, the Global RNA Interference (RNAi) Pesticides Market is accounted for $1.40 billion in 2024 and is expected to reach $2.75 billion by 2030 growing at a CAGR of 11.92% during ... Read More
-
Oligonucleotide Synthesis Market by Application Area (Research and Diagnostics, and Therapeutics), Type of Product Synthesized (Active Pharmaceutical Ingredients and Finished Dosage Forms), Type of Oligonucleotide Synthesized (Antisense, DNA, siRNA and Other Oligonucleotides), Scale of Operation (Clinical and Commercial), Therapeutic Area (Cardiovascular Disorders, Genetic Disorders, Liver Disorders, Rare Diseases, and Other Disorders), End-Users (Pharmaceutical / Biopharmaceutical Companies, Academic and Research Institutes, and Hospitals), Company Size (Small, Mid-sized, and Large and Very Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... (Clinical and Commercial), Therapeutic Area (Cardiovascular Disorders, Genetic Disorders, Liver Disorders, Rare Diseases, and Other Disorders), End-Users (Pharmaceutical / Biopharmaceutical Companies, Academic and Research Institutes, and Hospitals), Company Size (Small, Mid-sized, and Large and Very ... Read More
-
Global Longevity and Anti-senescence Therapy Market 2025-2029
... the longevity and anti-senescence therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding ... Read More
-
Global Antisense & RNAi Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... USD 986.3 million in 2023 and is forecast to a readjusted size of USD 1303.9 million by 2030 with a CAGR of 4.1% during review period. Antisense therapy is a form of treatment for genetic ... Read More
-
Antisense and RNAi Therapeutics
... reach US$3.6 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2023-2030. Antisense RNA Technology, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
RNAi Technologies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented from 2019 ... Read More
-
RNAi for Therapeutic Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type
... its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented ... Read More
-
Antisense & RNAi Therapeutics – A Global Market Overview
... utilizes synthetic nucleic acids called antisense oligonucleotides (ASOs) that bind to specific messenger RNA (mRNA) sequences, effectively silencing disease-associated genes. RNAi employs double-stranded RNA (dsRNA) to produce small interfering RNA (siRNA) and microRNA (miRNA) that ... Read More
-
RNAi Pesticides Market - A Global and Regional Analysis: Focus on Application, Product, and Competitive Landscape - Analysis and Forecast, 2024-2034
... within the broader agricultural industry, focusing on innovative pest control solutions that utilize RNA interference technology. In a favorable scenario, the market is valued at $1.20 billion in 2024 and is projected to expand at ... Read More
-
Global RNAi Technologies Market Research Report 2024(Status and Outlook)
... field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and ... Read More
-
Global Microrna (mirna) Market 2024-2028
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Global RNA Based Therapeutics Market 2024-2028
... period. The report on the RNA based therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Nucleic Acid Therapeutics Market Size study, by Product (Anti-Sense Oligonucleotides (ASO), RNA Interference (RNAi), RNA Aptamers), by Indication (Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, Others), by End-user (Hospitals, Physicians’ Offices, Others), and Regional Forecasts 2022-2032
... Forecasts 2022-2032 The Global Nucleic Acid Therapeutics Market was valued at approximately USD 6.0 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 12.8% over the forecast period ... Read More
-
Global RNAi-based Biopesticides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... this mechanism to control pests by silencing essential genes in target organisms, leading to their death or reduced fitness. According to our (Global Info Research) latest study, the global RNAi-based Biopesticides market size was valued ... Read More
-
Global RNAi for Therapeutic Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the ... Read More
-
Global RNAi for Therapeutic Market Analysis and Forecast 2024-2030
... was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is ... Read More
-
Global RNAi for Therapeutic Market Size, Manufacturers, Opportunities and Forecast to 2030
... molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi ... Read More
-
Global RNAi for Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that ... Read More
-
Nucleic Acid Therapeutics Market [Product: Anti-Sense Oligonucleotides (ASO), RNA Interference (RNAi), and RNA Aptamers; and Indication: Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, and Others] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... 2024-2034 Nucleic Acid Therapeutics Market – Scope of Report TMR’s report on the global nucleic acid therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights of ... Read More
-
Global RNAi-based Biopesticides Market Growth 2024-2030
... genes in target organisms, leading to their death or reduced fitness. The global RNAi-based Biopesticides market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to ... Read More
-
Nucleic Acid Therapeutics Market (Product Type: RNA interference (RNAi) and Short Interfering RNAs, Antisense Oligonucleotides (ASOs), and Others; and Application: Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Growth, Trends, and Forecast, 2024-2034 Nucleic Acid Therapeutics Market – Scope of Report TMR’s report on the global nucleic acid therapeutics market studies the past as well as the current growth trends and opportunities to ... Read More
-
Global Rnai Drug Delivery Market 2024-2028
... forecast period. The report on the RNAi drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
RNA Interference (RNAi)
... by 2030, growing at a CAGR of 11.0% over the analysis period 2023-2030. Drug Discovery & Development Application, one of the segments analyzed in the report, is expected to record a 16.4% CAGR and reach ... Read More